Most lately, it's been identified that conolidine and the above mentioned derivatives act on the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts being a scavenger https://mannerse531hjj3.ziblogs.com/profile